GlobeNewswire

HPIL HOLDING Creates a Mutually Beneficial Relationship With the World Traditional Okinawa Karate Federation (WTOKF) in 2018 and Beyond

Dela

Company Sponsors and Supports WTOKF Activities Worldwide as Karate Gets Introduced into the Next Summer Olympic Games

 

SANFORD, Mich., March 06, 2018 (GLOBE NEWSWIRE) -- HPIL HOLDING (the "Company") (OTC Pink:HPIL) announced today that through its agreement with the World Traditional Okinawa Karate Federation (WTOKF), the worldwide karate governing body, the Company continues to create a strong and mutually beneficial relationship with the WTOKF through sponsorships and the support of a variety of activities which are WTOKF-related around the world.   

A number of major events are in store during 2018 which include: The INTERNATIONAL KARATE GASSHUKU in Luzern, Switzerland and the EUROPEAN KARATE CHAMPIONSHIP in Rome, Italy 2018 - these activities are sponsored as well by HPIL HOLDING, as WTOKF's Official Sponsor.  In the past, the WTOKF has been responsible for successfully organizing 13 European Championships, 7 World Championships along with annual training sessions, and International Karate Seminars (Gasshuku).

The WTOKF is an internationally recognized world entity with 84 affiliated member countries worldwide, registered officially in 8834 Schindellegi, Etzelblickstrasse 1, Switzerland.

The purpose of the WTOKF is to constantly improve karate, to globally promote the idea of unifying, educational, cultural and humanitarian values of karate, specifically by promoting youth and development programs, to organize our own international competitions, to set rules and regulations and to ensure their enforcement and to monitor, by the WTOKF.

In addition, the WTOKF will also focus on the development of Karate activities and events in each member country in order to increase the number of practitioners and in the end to permanently raise the level of training of each WTOKF member organization.

In all of these Karate activities and events, the WTOKF works with  the support of HPIL HOLDING.

"Based on the existing agreement, we have great development plans and joint projects for the future," said Hanshi Ionel Bara, President of the World Traditional Okinawa Karate Federation. "We consider this collaboration beneficial to both parties, as we continue to move forward with our events and other activities in 2018, we are grateful for the support and sponsorship of HPIL HOLDING as Official Sponsor of the World Traditional Okinawa Karate Federation (WTOKF)."

Bara continued, "Our collaboration with HPIL HOLDING has been fruitful since its inception, thanks especially to HPIL's Chairman and CEO, Nitin Amersey, whose many years of experience in corporate management, international trade &  marketing and brand creation  have been a vital part of the success of the WTOKF."

Bara said the WTOKF is counting on all Karate organizations and federations around the world and of all practitioners of martial arts, to finally realize the dream of all karateka, for karate to be recognized as an Olympic game in the upcoming 2020 Summer Olympics being held in Tokyo, Japan.

HPIL has entered into a licensing agreement in the US market for use of the WTOKF logo and brand and is seeking licensees worldwide for karate and other apparel and products.

The web site for the WTOKF is https://wtokf.org/

HPIL HOLDING (http://HPILHOLDING.COM) is a holding company listed on OTC Markets.

Safe Harbor / Forward-Looking Statements:

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "plan," "potential," "seek," and "intend," among others. These forward-looking statements are based on the Company's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our possible need for financing; uncertainties of technological changes; and dependence upon third parties. The Company does not undertake an obligation to update or revise any forward-looking statement. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.

HPIL HOLDING

For more information, please contact: 

Mr. Peter Nicosia
Tel:  +1(248)750-1015

Email: info@hpilholding.com
Source: HPIL HOLDING

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f221a1ee-781d-4967-b34a-7a602ff06ebf




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: HPIL HOLDING via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum